Ophthalmic losses during surgical correction of valvular heart disease


  • S.O. Rykov Shupyk National Medical Academy of Postgraduate Education, Kyiv, Ukraine
  • O.V. Petrenko Shupyk National Medical Academy of Postgraduate Education, Kyiv, Ukraine
  • N.Ya. Kovalchuk SI “Heart Institute of the Ministry of Health of Ukraine”, Kyiv, Ukraine




ophthalmic complications, valve pathology of the heart, cardiac surgery, review


Valve pathology of the heart is the third most common cardiovascular disease after coronary heart disease and hypertension. In Ukraine, about 0.4 % of the population has acquired heart disease. The main method of treatment of acquired defects is surgery. Timely cardiac surgery can prolong life for decades in 75–80 % of patients. The trend of modern cardiac surgery is minimally invasive. This gives a better cosmetic effect and faster rehabilitation for patients, but it is a more capacious and complex technique for the surgeon, slightly prolongs the time of artificial circulation, aortic compression, and accordingly, the risk of complications. The article analyzes the main possible complications from the organ of vision during surgical corrections of valvular heart disease. It was found that ophthalmic complications in most literature sources are considered as part of neurological disorders after heart surgery. Today we have a need to study the features of the course and prevention of ophthalmic complications among the group of patients with the highest risk of microembolic and ischemic changes of the retina and optic nerve on the background of valvular heart disease, structuring of material, selection of risk groups preparing for cardiac surgery.


Atanassova P.A. Antiphospholipid syndrome and vascular ischemic (occlusive) diseases: an overview. Yonsei Med. J. 2007. 48(6). 901-926. doi:10.3349/ymj.2007.48.6.901.

Barbut D., Hinton R.B., Szatrowski T.P. et al. Cerebral emboli detected during bypass surgery are associated with clamp removal. Stroke. 1994. 25(12). 2398-2402. doi:10.1161/01.str.25.12.2398.

Beach J.M., Mihaljevic T., Svensson L.G. et al. Coronary artery disease and outcomes of aortic valve replacement for severe aortic stenosis. J. Am. Coll. Cardiol. 2013. 61(8). 837-848. doi:10.1016/j.jacc.2012.10.049.

Bojikian K.D., Chen C.L., Wen J.C. et al. Optic Disc Perfusion in Primary Open Angle and Normal Tension Glaucoma Eyes Using Optical Coherence Tomography-Based Microangiography. PLoS One. 2016. 11(5). e0154691. Published 2016 May 5. doi:10.1371/journal.pone.0154691.

Calway T., Rubin D.S., Moss H.E., Joslin C.E., Beckmann K., Roth S. Perioperative Retinal Artery Occlusion: Risk Factors in Cardiac Surgery from the United States National Inpatient Sample 1998–2013. Ophthalmology. 2017. 124(2). 189-196. doi:10.1016/j.ophtha.2016.10.025.

Cannegieter S.C., Rosendaal F.R., Wintzen A.R., van der Meer F.J., Vandenbroucke J.P., Briët E. Optimal oral anticoagulant therapy in patients with mechanical heart valves. N. Engl. J. Med. 1995. 333(1). 11-17. doi:10.1056/NEJM199507063330103.

Chapin J., Carlson K., Christos P.J., DeSancho M.T. Risk Factors and Treatment Strategies in Patients With Retinal Vascular Occlusions. Clinical and Applied Thrombosis/Hemostasis. 2013. 21(7). 672-677. URL: https://doi.org/10.1177/ 1076029613513320.

Chua B., Kifley A., Wong T.Y., Mitchell P. Homocysteine and retinal vein occlusion: a population-based study. American Journal of Ophthalmology. 2005 Jan. 139(1). 181-182. DOI: 10.1016/j.ajo.2004.06.084.

Ciulla T.A., Harris A., Kagemann L., Danis R.P., Pratt L.M., Chung H.S., Weinberger D., Garzozi H.J. Choroidal perfusion perturbations in non-neovascular age related macular degeneration. Br. J. Ophthalmol. 2002. 86. 209-13.

d’Arcy J.L., Prendergast B.D., Chambers J.B., Ray S.G., Bridgewater B. Valvular heart disease: the next cardiac epidemic [published correction appears in Heart. 2011 Jul. 97(13). 1112]. Heart. 2011. 97(2). 91-93. doi:10.1136/hrt.2010.205096.

Falk V., Baumgartner H., Bax J.J. et al. 2017 ESC/EACTS Guidelines for the management of valvular heart disease [published correction appears in Eur. J. Cardiothorac. Surg. 2017 Oct 1. 52(4). 832]. Eur. J. Cardiothorac. Surg. 2017. 52(4). 616-664. doi:10.1093/ejcts/ezx324.

Fleming A.D., Goatman K.A., Philip S., Williams G.J., Prescott G.J., Scotland, G.S., McNamee P., Leese G.P., Wykes W.N., Sharp P.F., Olson J.A., Scottish Diabetic Retinopathy Clinical Research Network. The role of haemorrhage and exudate detection in automated grading of diabetic retinopathy. British Journal of Ophthalmology. 2010. 94(6). 706-711. URL: https://doi.org/10.1136/bjo.2008.149807.

Floyd T.F., Shah P.N., Price C.C. et al. Clinically silent cerebral ischemic events after cardiac surgery: their incidence, regional vascular occurrence, and procedural dependence. Ann. Thorac. Surg. 2006. 81(6). 2160-2166. doi:10.1016/j.athoracsur.2006.01.080.

Hattenhauer M.G., Leavitt J.A., Hodge D.O., Grill R., Gray D.T. Incidence of nonarteritic anterior ischemic optic neuropathy. Am. J. Ophthalmol. 1997. 123(1). 103-107. doi:10.1016/s0002-9394(14)70999-7.

Iung B., Baron G., Butchart E.G. et al. A prospective survey of patients with valvular heart disease in Europe: The Euro Heart Survey on Valvular Heart Disease. Eur. Heart J. 2003. 24(13). 1231-1243. doi:10.1016/s0195-668x(03)00201-x.

Johnson L.N., Arnold A.C. Incidence of nonarteritic and arteritic anterior ischemic optic neuropathy. Population-based study in the state of Missouri and Los Angeles County, California. J. Neuro­ophthalmol. 1994. 14(1). 38-44.

Kalyani S.D., Miller N.R., Dong L.M., Baumgartner W.A., Alejo D.E., Gilbert T.B. Incidence of and risk factors for perioperative optic neuropathy after cardiac surgery. Ann. Thorac. Surg. 2004. 78. 34-7.

Massaro A., Messé S.R., Acker M.A. et al. Pathogene­sis and Risk Factors for Cerebral Infarct After Surgical Aortic Valve Replacement. Stroke. 2016. 47(8). 2130-2132. doi:10.1161/STROKEAHA.116.013970.

Messé S.R., Acker M.A., Kasner S.E. et al. Stroke after aortic valve surgery: results from a prospective cohort. Circulation. 2014. 129(22). 2253-2261. doi:10.1161/CIRCULATIONAHA.113.005084.

Nuttall G.A., Garrity J.A., Dearani J.A., Abel M.D., Schroe­der D.R., Mullany C.J. Risk factors for ischemic optic neuropathy after cardiopulmonary bypass: a matched case/control study. Anesth. Analg. 2001. 93(6). doi:10.1097/00000539-200112000-00012.

Ohtake H., Misaki T., Matsunaga Y., Tubota M., Watanabe Y., Shirao Y. Open heart surgery under total extracorporeal circulation in a patient with advanced glaucoma. Cardiovasc. Surg. 1993. 1. 190-1.

Palmowski A.M., Denninger E., Geisel J., Pindur G., Rup­recht K.W. Antiphospholipid antibodies in ocular arterial and venous occlusive disease. Invest. Ophthalmol. Vis. Sci. 2004. 45(13). 1587.

Ramakrishna G., Malouf J.F., Younge B.R., Connolly H.M., Miller F.A. Calcific retinal embolism as an indicator of severe unrecognised cardiovascular disease. Heart. 2005. 91(9). 1154-1157. doi:10.1136/hrt.2004.041814.

Rubin D.S., Matsumoto M.M., Moss H.E., Joslin C.E., Tung A., Roth S. Ischemic Optic Neuropathy in Cardiac Surgery: Incidence and Risk Factors in the United States from the National Inpatient Sample 1998 to 2013. Anesthesiology. 2017. 126(5). 810-821. doi:10.1097/ALN.0000000000001533.

Rudkin A.K., Lee A.W., Chen C.S. Vascular risk factors for central retinal artery occlusion. Eye (Lond). 2010. 24(4). 678-681. doi:10.1038/eye.2009.142.

Sakata R., Aihara M., Murata H. et al. Contributing factors for progression of visual field loss in normal-tension glaucoma patients with medical treatment. J. Glaucoma. 2013. 22(3). 250-254. doi:10.1097/IJG.0b013e31823298fb.

Schmidt D., Hetzel A., Geibel-Zehender A., Schulte-Mön­ting J. Systemic diseases in non-inflammatory branch and central retinal artery occlusion — an overview of 416 patients. Eur. J. Med. Res. 2007. 12(12). 595-603.

Selim M. Perioperative stroke. N. Engl. J. Med. 2007. 356(7). 706-713. doi:10.1056/NEJMra062668.

Shapira O.M., Kimmel W.A., Lindsey P.S., Shahian D.M. Anterior ischemic optic neuropathy after open heart operations. Ann. Thorac. Surg. 1996. 61. 660-6.

Shaw P.J. The incidence and nature of neurological morbidity following cardiac surgery: a review. Perfusion. 1989. 4(2). 83-91. URL: https://doi.org/10.1177/026765918900400202.

Varma D.D., Cugati S., Lee A.W., Chen C.S. A review of central retinal artery occlusion: clinical presentation and management. Eye (Lond). 2013. 27(6). 688-697. doi:10.1038/eye.2013.25.

Бураковский В.И., Рапопорт Я.Л., Гельштейн Г.Г. и др. Осложнения при операциях на открытом сердце. М.: Медицина, 1972. 304 с.

Гандзюк В.А. Аналіз захворюваності на ішемічну хворобу серця в Україні. Український кардіологічний журнал. 2014. 3. 45-52.

Гогаєва О.К., Руденко А.В., Лазоришинець В.В. Неврологічні ускладнення після вінцевого шунтування пацієнтів високого ризику: сучасний стан проблеми. Український журнал серцево-судинної хірургії. 2020. 2(39), 15-17. URL: https://doi.org/10.30702/ujcvs/20.3905/022015-017.

Орлов В.И., Мурзабекова Л.И. Кардиохирургическое лечение пациентов с приобретенными пороками сердца: отдаленные результаты и клинические факторы, влияющие на них. Российский кардиологический журнал. 2005. (5). 87-94. URL: https://doi.org/10.15829/1560-4071-2005-5-87-94.

Пастухова А.А., Котвицкая А.А. Анализ показателей заболеваемости и распространенности болезней глаза и его придаткового аппарата среди пожилого населения Украины. Материалы IX годичной научно-практ. конф. молодых ученых и студентов ТГМУ им. Абуали ибни Сино с междунар. участием «Достижения и перспективы развития медицинской науки», 25 апреля 2014 г., Душанбе. Душанбе, 2014. С. 269.

Усенко О.Ю., Габрієлян А.В., Нікульніков П.І., Белейович В.В., Ратушнюк А.В., Пилипас О.Ю. Діагностично-лікувальний алгоритм у хворих з поєднаними атеросклеротичними ураженнями вінцевих та брахіоцефальних артерій. Вісник серцево-судинної хірургії. 2017. № 1. С. 42-46. URL: http://nbuv.gov.ua/UJRN/shnp_2017_1_12.





Literature Review, Discussions